Show
Sort by
-
The ION-Ghent guidelines for the management of immune related adverse events (irAE's)
-
Systemic immune changes associated with adjuvant interferon-α2b-therapy in stage III melanoma patients: failure at the effector phase?
-
Characterization of the in vivo immune network of IDO, tryptophan metabolism, PD-L1, and CTLA-4 in circulating immune cells in melanoma
-
- Journal Article
- A1
- open access
Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma
-
Peritumoral indoleamine 2,3-dioxygenase expression in melanoma : an early marker of resistance to immune control?
-
- Journal Article
- A1
- open access
Incidental radiological finding of a renal tumour leading to the diagnosis of Birt-Hogg-Dubé syndrome